| 000 | 02694na a2200457 4500 | ||
|---|---|---|---|
| 003 | PC981 | ||
| 005 | 20180417112750.0 | ||
| 008 | 130622s2012 xxx||||| |||| 00| 0 eng d | ||
| 040 | _cH12O | ||
| 041 | _aeng | ||
| 100 | _aBarrio, Francisco | ||
| 100 | _aBoutriau, Dominique | ||
| 100 | _aCabanillas, Lucia | ||
| 100 | _aCaubet, Magalie | ||
| 100 | _aCenteno, Fernando | ||
| 100 | _aDe Torres, Maria Jose | ||
| 100 | _aEspín, José | ||
| 100 | _aEsporrin, Carlos | ||
| 100 | _aGarcía-Sicilia, José | ||
| 100 | _aMerino, José Manuel | ||
| 100 | _aMesaros, Narcisa | ||
| 100 | _aMiller, Jacqueline M | ||
| 100 | _aMoreno-Pérez, David | ||
| 100 | _aMoro, Manuel | ||
| 100 | _aMuro, Marta | ||
| 100 | _aNavarro, Maria-Luisa | ||
| 100 | _aOmeñaca, Félix | ||
| 100 | _aRuiz-Contreras, Jesús | ||
| 100 |
_aRuiz Contreras, Jesús _9811 _ePediatría |
||
| 245 | 0 | 0 |
_aFive-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine. _h[artículo] |
| 260 |
_bThe Pediatric infectious disease journal, _c2012 |
||
| 260 | _c2012 | ||
| 300 | _a31(10):1074-7. | ||
| 500 | _aFormato Vancouver: Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F et al. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J. 2012 Oct;31(10):1074-7. | ||
| 501 | _aTejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F, García-Sicilia J, Moreno-Pérez D, Ruiz-Contreras J, Centeno F, Barrio F, Cabanillas L, Muro M, Esporrin C, De Torres MJ, Caubet M, Boutriau D, Miller JM, Mesaros N. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J. 2012 Oct;31(10):1074-7. | ||
| 504 | _aContiene 19 referencias | ||
| 520 | _aBACKGROUND: Booster vaccination with the combined Haemophilus influenza type b-Neisseria meningitides serogroup C-tetanus toxoid vaccine (Hib-MenC-TT) has been reported to induce different MenC antibody responses depending on the priming vaccines, with a possible impact on long-term protection. Here, the five-year persistence of immune responses induced by a booster dose of Hib-MenC-TT was evaluated in toddlers primed with either Hib-MenC-TT or MenC-TT. | ||
| 710 |
_9446 _aServicio de Pediatría-Neonatología |
||
| 856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/9/pc981.pdf _ySolicitar documento |
||
| 942 |
_n0 _2ddc _cART |
||
| 999 |
_c981 _d981 |
||